Triple-Negative Breast Cancer Research and Education Act of 2025

This bill focuses on triple-negative breast cancer (TNBC), a fast-growing and hard-to-treat type of breast cancer. It notes that TNBC hits some groups harder, especially African-American and Hispanic women, and that early detection saves lives. The bill says more data is needed on how common TNBC is in these communities, how much treatment costs, and how to prevent or cure it.

It would boost federal research and public education on TNBC. The National Institutes of Health must expand and coordinate research. The Centers for Disease Control and Prevention must share clear information with the public about how common TNBC is, who faces higher risk, and what treatments exist. The Health Resources and Services Administration must keep doctors updated on TNBC and its higher risks for minority women. Funding is authorized as needed for these efforts from fiscal years 2026 through 2031. “Minority women” is defined as women who are members of racial and ethnic minority groups .

• Who is affected: Women with or at risk for TNBC (especially African-American and Hispanic women), their families, health care providers, and researchers.
• What changes: More NIH research; CDC public education about risks and treatment options; HRSA guidance for health care providers; information can be shared directly or through trusted organizations and media.
• When: Funding is authorized for fiscal years 2026–2031 to carry out these activities.